Trial Profile
2-phased Randomized Comparison Between Promus Element Versus Xience PRIME Stent
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions
- Acronyms ANCHOR
- 30 Apr 2012 New trial record